Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
Satoshi ShinozakiHiroyuki OsawaYasutoshi KobayashiHirotsugu SakamotoYoshikazu HayashiYoshimasa MiuraAlan Kawarai LeforHironori YamamotoPublished in: Scandinavian journal of gastroenterology (2018)
One-year treatment with vonoprazan significantly improves GERD symptoms and endoscopic healing of erosive esophagitis is satisfactory. The long-term use of vonoprazan is effective and useful to control GERD.